Our hereditary cancer panels, developed by Mayo Clinic oncologists and backed by genetic counselors, utilize next- generation sequencing to evaluate dozens of genes associated with cancer risk. Test results, analyzed by Mayo Clinic experts, enable precision insights for individuals identified with hereditary cancer syndromes and those who are not.
Our hereditary cancer panels provide family members with a deeper understanding of their risk for developing certain types of cancer, which can be helpful in planning for the future. Our comprehensive germline cancer analyses complement our somatic offerings, allowing for streamlined cancer evaluations in one laboratory.
1 in 8
1 in 8 patients have a germline variant1
50+ hereditary cancer syndromes have been described2
33% of patients identified to have germline variants benefit from TAILORED cancer treatment3
Fill out the form below and one of our specialists will be in touch.